Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization

Platelets

Volumn 21, Issue 3, 2010, Pages 183-190

  Gao, Peixian ^a,b   Xiong, Hui ^a   Zheng, Zhe ^a,b   Li, Lihuan ^a   Gao, Runlin ^c   Hu, Sheng Shou ^a,b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b BEIJING HOSPITAL   (China)

^c FUWAI HOSPITAL   (China)

Author keywords

Antiplatelet therapy; Hybrid revascularization; Percutaneous coronary intervention; Platelet aggregation

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; AMIODARONE; ARACHIDONIC ACID; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN CELL; LOADING DRUG DOSE; LUNG EMBOLISM; MAINTENANCE DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; TREATMENT DURATION;

ADENOSINE DIPHOSPHATE; ANGIOPLASTY, BALLOON, CORONARY; ARACHIDONIC ACID; ASPIRIN; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PROSPECTIVE STUDIES; TICLOPIDINE;

EID: 77951279160     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537101003592700     Document Type: Article

References (27)

1. Reicher B, Poston RS, Mehra MR, Joshi A, Odonkor P, Kon Z, Reyes PA, Zimrin DA. Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: Feasibility, safety, and clinical outcomes. Am Heart J 2008;155:661-667.
2. Kon ZN, Brown EN, Tran R, Joshi A, Reicher B, Grant MC, Kallam S, Burris N, Connerney I, Zimrin D, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg 2008;135:367-375.
3. Kiaii B, McClure RS, Stewart P, Rayman R, Swinamer SA, Suematsu Y, Fox S, Higgins J, Albion C, Kostuk WJ, et al. Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up. J Thorac Cardiovasc Surg 2008;136:702-708.
4. Hu SS. One-stop hybrid approach for cardiovascular disease: From conception to practice. Ann Thorac Cardiovasc Surg 2008;14:345-346.
5. Bonatti J, Schachner T, Bonaros N, Jonetzko P, Ohlinger A, Ruetzler E, Kolbitsch C, Feuchtner G, Laufer G, Pachinger O, et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study. Cardiology 2008;110:92-95.
6. Kiaii B, McClure RS, Kostuk WJ, Rayman R, Swinamer S, Dobkowski WB, Novick RJ. Concurrent robotic hybrid revascularization using an enhanced operative suite. Chest 2005;128:4046-4048.
7. Byrne JG, Leacche M, Vaughan DE, Zhao DX. Hybrid cardiovascular procedures. JACC Cardiovasc Interv 2008;1:459-468.
8. Poston RS, Tran R, Collins M, Reynolds M, Connerney I, Reicher B, Zimrin D, Griffith BP, Bartlett ST. Comparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniques. Ann Surg 2008;248:638-646.
9. Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, Cohn LH. Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. J Am Coll Cardiol 2005;45:14-18.
10. Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004;110:e489-493.
11. Yang YJ, Xu B, Chen JL, Kang S, Qiao SB, Qin XW, Yao M, Chen J, Wu YJ, Liu HB, et al. Comparison of immediate and followup results between transradial and transfemoral approach for percutaneous coronary intervention in true bifurcational lesions. Chin Med J (Engl) 2007;120: 539-544.
12. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA. Variability in individual responsiveness to clopidogrel: Clinical implications, management, and future perspectives. J Am Coll Cardiol 2007;49: 1505-1516.
13. Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: Implications of aspirin resistance. J Am Coll Cardiol 2008;51:1829-1843.
14. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
15. Shim JH, Jo WM, Chung WJ, Chung JH. Unexpected stent thrombus after minimally invasive direct coronary artery bypass in hybrid re-vascularisation. Eur J Cardiothorac Surg 2009;419-421.
16. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007;49:2145-2150.
17. Bednar F, Osmancik P, Vanek T, Mocikova H, Jares M, Straka Z, Widimsky P. Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: Results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET). J Thorac Cardiovasc Surg 2008;136:1054-1060.
18. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US. Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005;46:1820-1826.
19. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-2913.
20. Zhao DX, Leacche M, Balaguer JM, Boudoulas KD, Damp JA, Greelish JP, Byrne JG, Ahmad RM, Ball SK, Cleator JH, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol 2009;53:232-241.
21. Maltais S, Perrault LP, Do QB. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: Impact of discontinuation prior to surgery. Eur J Cardiothorac Surg 2008;34:127-131.
22. Levine JC, Feseha H, KL M. Safety and efficacy of platelet inhibition during hybrid coronary revascularization CHEST 2007;132:467S-468S.
23. L'Allier PL, Ducrocq G, Pranno N, Noble S, Ibrahim R, Gregoire JC, Azzari F, Nozza A, Berry C, Doucet S, et al. Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: Results from the PREPAIR randomized study. J Am Coll Cardiol 2008;51:1066-1072.
24. Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, et al. The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: The PRINC (Plavix Response in Coronary Intervention) trial. JACC Cardiovasc Interv 2008;1:612-619.
25. Palmer GJ, Sankaran IS, Sparkman GM, Koster A, Dyke CM, Ebra G. Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective. Heart Surg Forum 2008;11:E24-29.
26. Murphy GS, Marymont JH. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2007;21:113-126.
27. Harrison P, Frelinger 3rd AL, Furman MI, Michelson AD. Measuring antiplatelet drug effects in the laboratory. Thromb Res 2007;120:323-336.